Identification of small molecular ligands as potent inhibitors of fatty acid metabolism in Mycobacterium tuberculosis
Autor: | Kiran Kumar Mustyala, Ramesh Malikanti, Uma Vuruputuri, Vasavi Malkhed, Hymavathi Veeravarapu, Rajender Vadija |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Virtual screening 030102 biochemistry & molecular biology Stereochemistry Drug discovery Chemistry Organic Chemistry Dehydrogenase Analytical Chemistry Inorganic Chemistry 03 medical and health sciences 030104 developmental biology Biochemistry Docking (molecular) Target protein Homology modeling Binding site Pharmacophore Spectroscopy |
Zdroj: | Journal of Molecular Structure. 1150:227-241 |
ISSN: | 0022-2860 |
DOI: | 10.1016/j.molstruc.2017.08.090 |
Popis: | Tuberculosis (Tb) is one of the major health challenges for the global scientific community. The 3-hydroxy butyryl-CoA dehydrogenase (Fad B2) protein belongs to 3-hydroxyl acetyl-CoA dehydrogenase family, which plays a key role in the fatty acid metabolism and β-oxidation in the cell membrane of Mycobacterium tuberculosis (Mtb). In the present study the Fad B2 protein is targeted for the identification of potential drug candidates for tuberculosis. The 3D model of the target protein Fad B2, was generated using homology modeling approach and was validated. The plausible binding site of the Fad B2 protein was identified from computational binding pocket prediction tools, which ranges from ASN120 to VAL150 amino acid residues. Virtual screening was carried out with the databases, Ligand box UOS and hit definder, at the binding site region. 133 docked complex structures were generated as an output. The identified ligands show good glide scores and glide energies. All the ligand molecules contain benzyl amine pharmacophore in common, which show specific and selective binding interactions with the SER122 and ASN146 residues of the Fad B2 protein. The ADME properties of all the ligand molecules were observed to be within the acceptable range. It is suggested from the result of the present study that the docked molecular structures with a benzyl amine pharmacophore act as potential ligands for Fad B2 protein binding and as leads in Tb drug discovery. |
Databáze: | OpenAIRE |
Externí odkaz: |